Literature DB >> 23557268

The genetic basis of resistance to HIV infection and disease progression.

Mara Biasin1, Mariacristina De Luca, Federica Gnudi, Mario Clerici.   

Abstract

Susceptibility to HIV infection and the modulation of disease progression are strictly dependent on inter-individual variability, much of which is secondary to host genetic heterogeneity. The study of host factors that control these phenomena relies not only on candidate gene approaches but also on unbiased genome-wide genetic and functional analyses. Additional new insights stem from the study of mechanisms that control the expression of host and viral genes, such as miRNA. The genetic host factors that have been suggested to be associated either with resistance to HIV-1 infection or with absent/delayed progression to AIDS are nevertheless unable to fully justify the phenomenon of differential susceptibility to HIV. Multidisciplinary approaches are needed to further analyze individuals who deviate from the expected response to HIV exposure/infection. Results of these analyses will facilitate the identification of novel targets that could be exploited in the setting up of innovative therapeutic or vaccine approaches.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23557268     DOI: 10.1586/eci.13.16

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  5 in total

1.  Genetic polymorphisms of Trim5a are associated with disease progression in acutely and chronically HIV-infected patients.

Authors:  Xin Sun; Wei Li; Wenzhen Liu; Rui Wang; Qunhui Li; Hao Wu
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  High Expression of Antiviral and Vitamin D Pathway Genes Are a Natural Characteristic of a Small Cohort of HIV-1-Exposed Seronegative Individuals.

Authors:  Wbeimar Aguilar-Jimenez; Irma Saulle; Daria Trabattoni; Francesca Vichi; Sergio Lo Caputo; Francesco Mazzotta; Maria T Rugeles; Mario Clerici; Mara Biasin
Journal:  Front Immunol       Date:  2017-02-13       Impact factor: 7.561

3.  VDR rs2228570 Polymorphism Is Related to Non-Progression to AIDS in Antiretroviral Therapy Naïve HIV-Infected Patients.

Authors:  María A Jiménez-Sousa; José Luis Jiménez; Amanda Fernández-Rodríguez; Oscar Brochado-Kith; José María Bellón; Félix Gutierrez; Cristina Díez; Enrique Bernal-Morell; Pompeyo Viciana; María A Muñoz-Fernández; Salvador Resino
Journal:  J Clin Med       Date:  2019-03-05       Impact factor: 4.241

4.  DBP rs16846876 and rs12512631 polymorphisms are associated with progression to AIDS naïve HIV-infected patients: a retrospective study.

Authors:  María Ángeles Jiménez-Sousa; José Luis Jiménez; Amanda Fernández-Rodríguez; José María Bellón; Carmen Rodríguez; Melchor Riera; Joaquín Portilla; Ángeles Castro; María Ángeles Muñoz-Fernández; Salvador Resino
Journal:  J Biomed Sci       Date:  2019-10-23       Impact factor: 8.410

5.  Polymorphisms in miRNAs Gene (146a, 149, 196a) and Susceptibility to ARV-associated Hepatotoxicity.

Authors:  Hari Om Singh; Sushma Jadhav; Dharmesh Samani; Tapan N Dhole
Journal:  Curr Genomics       Date:  2019-02       Impact factor: 2.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.